Tarsus Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Tarsus Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Tarsus Pharmaceuticals Inc
Rating: 1.095361125
Author: Trendlyne DVM scores

Momentum Trap

about

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class the...

64.54 -1.17 (-1.78%)

67.59% Gain from 52W Low

447.1K

XNAS Volume

XNAS 30 Jan, 2026 4:30 PM (EST)

Low Financial Strength

11.1 / 100

Expensive Valuation

11.7 / 100

Technically Neutral

53.7 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 36%

9 analysts

Tarsus Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Tarsus Pharma Inc Live Stock Price Today, Share Analysis and Chart

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class the...

67.59% Gain from 52W Low

SWOT Analysis

Tarsus Pharma Inc Live Price Chart